Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancements in Stem Cell Manufacturing and Preservation
4.2.2 Growing Public Awareness About the Therapeutic Potency of Stem Cell Products
4.2.3 Growing Public-Private Investments and Funding in Stem Cell-Based Research
4.3 Market Restraints
4.3.1 High Operational Costs Associated With Stem Cell Manufacturing and Banking
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Culture Media
5.1.2 Consumables
5.1.3 Instruments
5.1.4 Stem Cell Lines
5.2 By Application
5.2.1 Stem Cell Therapy
5.2.2 Drug Discovery and Development
5.2.3 Stem Cell Banking
5.2.4 Others
5.3 By End-User
5.3.1 Pharmaceutical and Biotechnology Companies
5.3.2 Cell Banks and Tissue Banks
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Anterogen
6.1.2 Becton, Dickinson and Company
6.1.3 Cellular Dynamics (Fujifilm Holdings Corporation)
6.1.4 Lonza Group
6.1.5 Stemcell Technologies
6.1.6 Medipost
6.1.7 Merck Group
6.1.8 Osiris Therapeutics
6.1.9 Pluristem Therapeutics
6.1.10 Bio-Rad Laboratories


7 MARKET OPPORTUNITIES AND FUTURE TRENDS